The global eyelid surgery market size was valued at USD 7.31 billion in 2024 and is projected to reach USD 10.15 billion by 2030, growing at a CAGR of 5.6% from 2025 to 2030. The market’s growth is primarily driven by the increasing prevalence of ocular infections and disorders, particularly among the expanding geriatric population, who are more prone to age-related eye conditions.

Common ocular conditions such as ptosis (droopy eyelids), blurred vision, and periorbital wrinkles are becoming increasingly prevalent among older adults. These conditions not only affect vision but also impact facial aesthetics, creating heightened demand for targeted surgical interventions like blepharoplasty. Blepharoplasty effectively removes excess fatty deposits, reduces eye puffiness, and can improve visual clarity, making it both a functional and cosmetic procedure.

The growing awareness of aesthetic enhancement across specific age demographics also plays a significant role in driving market adoption. Blepharoplasty enhances the appearance of the eyes by correcting visible imperfections and creating a more youthful look. The influence of social media platforms such as YouTube, Instagram, and TikTok has further fueled interest, especially among younger demographics like Generation Z, who are constantly exposed to new skincare trends, beauty treatments, and cosmetic procedures. This exposure has helped normalize cosmetic interventions as tools for enhancing personal appearance.

Another important factor propelling the market is the combination of an aging global population and the associated decline in peripheral vision. According to the American Society of Plastic Surgery report (2023), most patients undergoing eyelid surgery are over the age of 40, highlighting the age-related demand for these procedures. Additionally, the Cleveland Clinic has emphasized that blepharoplasty is suitable for healthy adults above 30, further expanding the potential patient base.

The availability of qualified surgeons globally also supports market growth, as patients have easier access to skilled professionals, simplifying the decision-making process for undergoing surgery. Reflecting this upward trend, the BBC reported that in the UK alone, 27,462 blepharoplasty procedures were performed in 2024, representing a 5% increase compared to 2023, demonstrating the rising acceptance and adoption of eyelid surgeries.

Key Market Trends & Insights:

• In 2024, North America dominated the global eyelid surgery market, capturing the largest share at 37.1%. This leadership is largely attributed to the region’s well-established healthcare infrastructure, higher awareness of cosmetic and functional eyelid procedures, and widespread availability of skilled surgeons. The region’s growing geriatric population and increasing demand for aesthetic enhancements further support market growth.

• Within North America, the U.S. eyelid surgery market accounted for a dominant 82.4% of the regional revenue share in 2024. Factors contributing to this dominance include advanced medical facilities, high healthcare spending, and strong consumer preference for cosmetic and reconstructive eyelid procedures. The U.S. market also benefits from extensive promotional campaigns and educational initiatives that raise awareness about the benefits of eyelid surgeries, thereby increasing adoption rates.

• By procedure type, upper eyelid surgeries held the largest share of 55.2% in 2024. This is driven by the high prevalence of conditions such as ptosis (droopy eyelids), excess skin, and periorbital wrinkles, which are effectively treated through upper eyelid interventions. The procedure not only improves vision in patients with drooping eyelids but also enhances facial aesthetics, making it the preferred choice among patients seeking both functional and cosmetic benefits.

• In terms of end-use, the clinics and spa centers segment accounted for the largest market share, representing 65.2% in 2024. This segment’s dominance can be attributed to the growing availability of specialized cosmetic clinics and medical spas that provide personalized eyelid surgery services. Clinics and spa centers offer convenient access to qualified surgeons, shorter wait times compared to hospitals, and a more patient-focused environment, which enhances patient experience and encourages procedure adoption.

Order a free sample PDF of the Eyelid Surgery Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 7.31 Billion

• 2030 Projected Market Size: USD 10.15 Billion

• CAGR (2025-2030): 5.6%

• North America: Largest market in 2024

Key Companies & Market Share Insights:

Some of the key companies operating in the global eyelid surgery market include Integra LifeSciences Corporation, Stanford Health Care, Surgical Holdings, Stryker, among others. The market is also characterized by a large number of independent practitioners and specialized clinics, which cater to both functional and cosmetic eyelid procedures. Industry players are increasingly implementing strategic initiatives such as geographic expansion—particularly in the Asia-Pacific region—and the adoption of technological advancements in surgical procedures to attract a broader patient base and enhance service offerings.

Integra LifeSciences is a prominent manufacturer of medical devices and surgical instruments. While the company does not specialize exclusively in eyelid surgery products, it provides a wide range of tools applicable to various surgical procedures, including ophthalmic and plastic surgeries. These instruments can support eyelid surgeries, particularly in assisting precision, safety, and surgical efficiency, making Integra a notable contributor to the market ecosystem.

Stanford Health Care offers a comprehensive portfolio of ophthalmology and plastic surgery services, which includes both functional and cosmetic eyelid surgeries. With a reputation for handling complex and specialized cases, the institution serves as a significant player in the market. Their expertise in advanced surgical techniques, combined with access to highly trained surgeons and state-of-the-art facilities, ensures high-quality outcomes for patients undergoing eyelid procedures.

Other key market participants, such as Surgical Holdings and Stryker, focus on providing advanced surgical equipment, consumables, and supportive technologies that enhance the precision, safety, and efficiency of eyelid surgeries. Collectively, these companies, alongside independent clinics and practitioners, are driving market growth by expanding accessibility, improving procedural outcomes, and integrating innovations that meet the evolving needs of patients globally.

Key Players

• Integra LifeSciences Corporation

• Stanford Health Care

• Surgical Holdings

• Stryker

• American Society of Plastic Surgeons

• London Bridge Plastic Surgery

• Montenegro Clinic of Plastic Surgery

• Shoyukai Medical Association

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The global eyelid surgery market is experiencing steady growth, driven by an aging population and increasing awareness of both functional and aesthetic benefits of procedures like blepharoplasty. The market is characterized by a diverse range of providers, including specialized clinics, hospitals, and independent practitioners. Technological advancements and a growing emphasis on cosmetic enhancements are contributing to the market's expansion. North America, particularly the United States, leads the market, with a significant share attributed to the high demand for eyelid surgeries and the availability of skilled surgeons. As the market continues to evolve, factors such as demographic shifts, technological innovations, and cultural influences are expected to shape its future trajectory.